• Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hybio Pharmaceutical Co Ltd

+ Add to Watchlist

300199:CH

31.300 CNY 0.090 0.29%

As of 03:00:29 ET on 09/23/2014.

Snapshot for Hybio Pharmaceutical Co Ltd (300199)

Open: 31.190 Day's Range: 30.100 - 31.440 Volume: 2,752,795
Previous Close: 31.210 52wk Range: 16.500 - 32.550 1-Yr Rtn: +72.36%

Stock Chart for 300199

No chart data available.
  • 300199:CH 31.300
  • 1D
  • 1M
  • 1Y
31.210
Interactive 300199 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300199

Current P/E Ratio (ttm) 91.8802
Estimated P/E(12/2014) 74.5238
Relative P/E vs. SZ399006 1.5761
Earnings Per Share (CNY) (ttm) 0.3407
Est. EPS (CNY) (12/2014) 0.4200
Est. PEG Ratio -
Market Cap (M CNY) 12,520.00
Shares Outstanding (M) 400.00
30 Day Average Volume 3,515,847
Price/Book (mrq) 10.6628
Price/Sale (ttm) 36.9021
Dividend Indicated Gross Yield -%
Cash Dividend (CNY) 0.0500
Dividend Ex-Date 04/26/2013
5 Year Dividend Growth -
Next Earnings Announcement 10/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300199

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 300199

Hybio Pharmaceutical Company Limited develops, produces and sells diverse peptide products. The Company's main products are desmopressin acetate injection fluids, thymopentin for injections, somatostatin for injections and terlipressin for injections.

Zeng ShaoguiChairmanYuan JianchengPresident
Ma YapingVP:R & DYu PinxiangVP:Production
More Company Profile & Key Executives for 300199

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil